CpG Island Methylator Phenotype is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage 3 Colon Cancer
      QxMD      Google Scholar   
Citation:
Gastroenterology vol 147 (3) 637-645
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
4
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA032291, CA33601, U10 CA077658, T32 DK007742, UO1CA152756, CA32291, P30 CA015704, P01 CA077852, U10 CA031946, CA77651, U10 CA033601, U54 CA143862, CA60138, U10 CA180821, U10 CA037447, U10 CA180850, F32CA1591555-01, U10 CA077651, U54CA143862, T32 CA009515, P01CA077852, 2T32DK007742-16, P01CA77852, CA77658, R01 CA115513, 5T32-CA009515-28/29, R01CA115513, U10 CA180867, U01 CA152756, CA31946, F32 CA159555, P30CA15704  
Corr. Author:
Stacey Shiovitz 
Authors:
                                   
Networks:
 
Study
CALGB-89803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
CALGB (Alliance) 89803, CRC, epigenetic factors, chemotherapy